SCHEMBL29671263

SCHEMBL29671263

CNC(=O)c1c(F)c(F)c(F)c(F)c1S(=O)(=O)N(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ HDAC6 Q9UBN7 6/20 0.38
▸ HDAC11 Q96DB2 5/20 0.38
▸ HDAC8 Q9BY41 5/20 0.38
▸ HDAC3 O15379 2/20 0.38
▸ CA1 P00915 4/20 0.34
▸ CA2 P00918 4/20 0.34
▸ MMP1 P03956 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ MMP8 P22894 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ CYP2C19 P33261 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ F2 P00734 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27020189 0.80 HDAC6 (0.34) SMN1; SMN2HDAC6HDAC11HDAC8HDAC3
SCHEMBL29671286 0.80 HDAC6 (0.34) HDAC6HDAC11HDAC8HDAC3CA1
SCHEMBL29671262 0.79 F2 (0.37) HDAC6HDAC11HDAC8HDAC3CA1
SCHEMBL29671232 0.79 HDAC6 (0.33) HDAC6HDAC11HDAC8HDAC3CA1
SCHEMBL29671254 0.77 GAA (0.62) SMN1; SMN2HDAC6HDAC11HDAC8HDAC3
SCHEMBL29671222 0.76 HDAC6 (0.32) HDAC6HDAC11HDAC8HDAC3CA1
SCHEMBL27020687 0.76 PKM (0.39) SMN1; SMN2HDAC6HDAC11HDAC8HDAC3
SCHEMBL4172084 0.74 HTT (0.50) SMN1; SMN2HDAC6HDAC11HDAC8HDAC3
SCHEMBL22909271 0.74 CA1 (0.43) SMN1; SMN2HDAC6HDAC11HDAC8HDAC3
SCHEMBL29671215 0.73 HDAC3 (0.31) HDAC6HDAC11HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof 2692372 ONTARIO, INC. (CA) 2026-02-24 — — US disclosed
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC (CA) 2022-09-08 — — US disclosed
CN-114502533-A Benzenesulfonamide derivatives and use thereof 2692372安大略公司 2022-05-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof NR2E1, NR2C2, NR3C1 SMN1; SMN2 1102/4885HDAC6 1241/4885HDAC11 1733/4885
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF BCR, ARSA, VHL SMN1; SMN2 1225/4885HDAC6 549/4885HDAC11 2800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback